Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Neurobiology of Aging
|
May 27, 2005
Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease
R Rademakers, K Sleegers, J Theuns, et al.
Journal of Neurology
|
January 5, 2002
Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease
B Dermaut, G Roks, J Theuns, et al.
Neuropathology and Applied Neurobiology
|
November 19, 2016
Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy
P Tacik, M Sanchez-Contreras, M DeTure, et al.
Neurology
|
April 12, 2012
Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin
E McDade, B F Boeve, T M Burrus, et al.
European Journal of Neurology
|
May 29, 2009
GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease
B Jasinska-Myga, C Wider, G Opala, et al.
Neurology
|
September 30, 2009
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations
J L Whitwell, C R Jack, B F Boeve, et al.
Neurology
|
March 4, 2009
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN
J L Whitwell, C R Jack, B F Boeve, et al.
Neurology
|
December 22, 2010
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
J L Whitwell, C R Jack, J E Parisi, et al.
Neurology
|
September 1, 2010
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology
K Kantarci, B F Boeve, Z K Wszolek, et al.
Neurology
|
July 15, 2011
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN
J L Whitwell, S D Weigand, J L Gunter, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Neurobiology of Aging
|
May 27, 2005
Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease
R Rademakers, K Sleegers, J Theuns, et al.
Journal of Neurology
|
January 5, 2002
Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease
B Dermaut, G Roks, J Theuns, et al.
Neuropathology and Applied Neurobiology
|
November 19, 2016
Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy
P Tacik, M Sanchez-Contreras, M DeTure, et al.
Neurology
|
April 12, 2012
Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin
E McDade, B F Boeve, T M Burrus, et al.
European Journal of Neurology
|
May 29, 2009
GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease
B Jasinska-Myga, C Wider, G Opala, et al.
Neurology
|
September 30, 2009
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations
J L Whitwell, C R Jack, B F Boeve, et al.
Neurology
|
March 4, 2009
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN
J L Whitwell, C R Jack, B F Boeve, et al.
Neurology
|
December 22, 2010
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
J L Whitwell, C R Jack, J E Parisi, et al.
Neurology
|
September 1, 2010
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology
K Kantarci, B F Boeve, Z K Wszolek, et al.
Neurology
|
July 15, 2011
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN
J L Whitwell, S D Weigand, J L Gunter, et al.
Page
of 4